VERTEX PHARMACEUTICALS INC / MA financial data

Symbol
VRTX on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260% % -7.2%
Quick Ratio 38% % 41%
Debt-to-equity 40% % 11%
Return On Assets 16% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 254,034,190 shares -1.1%
Common Stock, Shares, Outstanding 253,991,224 shares -1.1%
Entity Public Float $113,400,000,000 USD -6.9%
Common Stock, Value, Issued $2,500,000 USD -3.8%
Weighted Average Number of Shares Outstanding, Basic 255,700,000 shares -0.85%
Weighted Average Number of Shares Outstanding, Diluted 258,000,000 shares 0.04%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $12,001,300,000 USD 8.9%
Costs and Expenses $7,828,000,000 USD -30%
Operating Income (Loss) $4,173,300,000 USD 18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $4,643,200,000 USD 1768%
Income Tax Expense (Benefit) $690,000,000 USD -12%
Net Income (Loss) Attributable to Parent $3,953,200,000 USD 30%
Earnings Per Share, Basic 15.46 USD/shares 33%
Earnings Per Share, Diluted 15.32 USD/shares 28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,084,800,000 USD 11%
Marketable Securities, Current $1,523,300,000 USD -1.5%
Accounts Receivable, after Allowance for Credit Loss, Current $2,052,800,000 USD 28%
Inventory, Net $1,686,800,000 USD 40%
Other Assets, Current $110,900,000 USD 45%
Assets, Current $11,201,000,000 USD 17%
Deferred Income Tax Assets, Net $2,897,900,000 USD 24%
Operating Lease, Right-of-Use Asset $1,562,700,000 USD 15%
Intangible Assets, Net (Excluding Goodwill) $424,200,000 USD -49%
Goodwill $1,088,000,000 USD 0%
Other Assets, Noncurrent $1,236,600,000 USD 24%
Assets $25,643,000,000 USD 14%
Accounts Payable, Current $461,700,000 USD 12%
Employee-related Liabilities, Current $397,700,000 USD 13%
Accrued Liabilities, Current $2,971,200,000 USD 6.5%
Liabilities, Current $3,861,200,000 USD 8.3%
Operating Lease, Liability, Noncurrent $1,846,500,000 USD 20%
Other Liabilities, Noncurrent $1,269,500,000 USD 25%
Liabilities $6,977,200,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $15,900,000 USD -112%
Retained Earnings (Accumulated Deficit) $13,560,000,000 USD 41%
Stockholders' Equity Attributable to Parent $18,665,800,000 USD 14%
Liabilities and Equity $25,643,000,000 USD 14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $818,900,000 USD -37%
Net Cash Provided by (Used in) Financing Activities $680,400,000 USD -90%
Net Cash Provided by (Used in) Investing Activities $55,800,000 USD 97%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 253,991,224 shares -1.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $113,200,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,087,800,000 USD 11%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,700,000 USD -73%
Deferred Tax Assets, Valuation Allowance $326,200,000 USD 20%
Deferred Tax Assets, Gross $3,723,900,000 USD 18%
Operating Lease, Liability $1,923,800,000 USD 18%
Payments to Acquire Property, Plant, and Equipment $40,700,000 USD -40%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $3,809,500,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid $3,199,500,000 USD 17%
Operating Lease, Liability, Current $77,300,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $196,900,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid, Year One $155,200,000 USD -7.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.0475 pure 3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,054,900,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $193,300,000 USD 22%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $852,100,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Four $139,900,000 USD -9.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $209,800,000 USD 1.3%
Deferred Tax Assets, Net of Valuation Allowance $3,397,700,000 USD 18%
Share-based Payment Arrangement, Expense $685,900,000 USD -1.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%